321 avenue Jean Jaurès
69007 LYON, FRANCE
Press relations: firstname.lastname@example.org
© Lyon biopole and www.b-rob.com
ENYO Pharma strengthens its leadership team with a NASH expert and announces that its Phase 1b trial in chronic HBV infected patients is on track with its FXR agonist EYP001.Ly...